BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 11/04/2024

FDA Clears Path for Baclofen Orally Disintegrating Tablets

The FDA has determined that KEMSTRO (baclofen) orally disintegrating tablets, 10 mg and 20 mg, were not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of generic versions.

Source: Federal Register — Food and Drug AdministrationOpen original release →